dipyridamole has been researched along with Cardiac Aneurysm in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, S | 1 |
| Hiroe, M | 1 |
| Amano, J | 1 |
| Shirai, T | 1 |
| Sugimoto, K | 1 |
| Miyahara, Y | 1 |
| Marumo, F | 1 |
1 other study available for dipyridamole and Cardiac Aneurysm
| Article | Year |
|---|---|
Hibernating myocardium associated with coronary artery dissection and vasospastic angina.
Topics: Angina Pectoris; Aortic Dissection; Coronary Angiography; Coronary Vasospasm; Dipyridamole; Heart An | 1992 |